Anticoagulation

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC71-14

DiraChart Clinical Reference
Protected section 14 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 14 of 15PreviousNext

Daily-note bank — change-of-condition / at-risk days

Scenario

Model daily note (edit to the shift)

Supratherapeutic INR

INR 5.2 (target 2.0–3.0), no active bleeding — warfarin held per protocol, provider notified, hold ± low-dose vitamin K and repeat INR ordered, representative notified, bleeding precautions and monitoring; recheck per order; supports Section N.

Active GI bleed

New melena with HR 104 and lightheadedness on an anticoagulant — anticoagulant held per parameters, vitals/orthostatics obtained, SBAR, labs/type-and-screen/evaluation (reversal consideration) ordered, representative notified, hemodynamic monitoring; reassess; supports Section N/I. (GI reference.)

Post-fall head strike

Fall with head strike on apixaban; new headache and drowsiness 30 min later — EMS/transfer activated, anticoagulant status communicated, provider and representative notified, neuro monitoring and time documented (delayed intracranial bleed). (Falls reference.)

Linked disease-specific scenarios

Atrial fibrillation and cardiac indications route to the Cardiovascular reference and CHF overlay; DVT/PE routes to the Peripheral Vascular reference; GI bleeding routes to the Gastrointestinal reference; post-fall delayed-bleed monitoring routes to the Falls reference; stroke routes to the Neurological reference.

Section NavigationPart 14 of 15PreviousNext